Katsumi Onai

Title: Innovations of Katsumi Onai

Introduction

Katsumi Onai is a notable inventor based in Aichi, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations for intravenous injection. With a total of 2 patents, his work has the potential to impact medical treatments significantly.

Latest Patents

One of his latest patents is titled "Pharmaceutical formulation comprising glycine as a stabilizer." This invention provides pharmaceutical formulations suitable for intravenous injection, which include a lyophilized anti-ulcerative agent reconstituted in isotonic solutions. These solutions are chemically and physically stable, maintaining their properties for extended periods. Another significant patent is "Injections containing lipid A analogues and process for the preparation thereof." This invention details a preparation for injection containing a lipid A analog, along with a process for its preparation, enhancing the efficiency of pharmaceutical applications.

Career Highlights

Katsumi Onai is currently associated with Eisai Company, Limited, where he continues to innovate in the pharmaceutical sector. His work focuses on improving drug formulations and delivery methods, which are crucial for patient care and treatment efficacy.

Collaborations

He has collaborated with notable colleagues such as Sumio Watanabe and Kiyoshi Iwamoto, contributing to a dynamic research environment that fosters innovation and development in pharmaceuticals.

Conclusion

Katsumi Onai's contributions to pharmaceutical formulations demonstrate his commitment to advancing medical science. His patents reflect a deep understanding of drug stability and delivery, which are essential for effective treatment options.